AUG 31, 2017 12:38 PM PDT

Two Immune Cell Types Accidentally Promote Heart Disease

WRITTEN BY: Kara Marker

Prescribing drugs that lower “bad” cholesterol is a common approach to treating heart disease, but scientists from the Karolinska Institute think there may be another solution.

Histopathology of atherosclerosis. Credit: Wikimedia User Pathos

Atherosclerosis, a disease characterized by the development of plaques in blood vessels that impede blood flow, is a common marker of heart disease. Immune cells called T cells and dendritic cells are regular occupiers of atherosclerotic plaques, where a collection of these cells and other debris floating through blood vessels ultimately pack together and block the flow of oxygenated blood to the heart. By targeting these immune cells, Karolinska Institute scientists believe they could develop a method for treating heart disease completely separate from techniques focused on lowering low-density lipoprotein (LDL), AKA “bad” cholesterol.

The main “ingredient” of this new technique is a protein called PCSK9 (proprotein convertase subtilisin kexin 9). PCSK9 proteins degrade LDL receptors, which results in increased amounts of LDL. Thus, PCSK9 inhibitors are prescribed to lower LDL cholesterol. But there’s yet another use for PCSK9 inhibitors.

The scientists needed to find a way to inhibit immune cells promoting the formation of atherosclerotic plaques without suppressing the entire immune system. So, they needed to know what specifically activates the T cells and dendritic cells found in atherosclerotic plaques. They discovered two key players: PCSK9 and oxidized LDL.

When LDL becomes oxidized, a modification is made to the lipoprotein that promotes its interaction with and uptake by macrophages, making oxidized LDL a clear marker for cardiovascular disease.

Researchers collected T cells from carotid arteries from people with atherosclerosis and from healthy individuals. Dendritic cells were taken from human peripheral blood. They combined dendritic cells with oxidized LDL before adding in T cells.

They found that oxidized LDL both triggered production of PCSK9 proteins and induced dendritic cell maturation and T cell activation into helper cells. However, inhibiting PCSK9 reversed the effects.

“This changed a pro-inflammatory profile into an anti-inflammatory state that is potentially anti-atherosclerotic,” explained lead author Prof Johan Frostegård. “The benefits of PCSK9 inhibition extend beyond lowering LDL cholesterol.”

Source: Methods in Molecular Biology, European Society of Cardiology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
AUG 13, 2019
Drug Discovery & Development
AUG 13, 2019
Novel Drug Target for Dilating Microvessels
Medical scientists at Augusta University have discovered a natural occurring chemical that dilates blood vessels dilate as well as signaling larger blood v...
AUG 20, 2019
Cell & Molecular Biology
AUG 20, 2019
Discovery of Bone Bits in Blood may Help Explain Vascular Calcification
As we age, calcium can build up in various tissues in the body, and cause them to harden in a process called calcification....
SEP 04, 2019
Health & Medicine
SEP 04, 2019
Are You Getting Enough Heart-Healthy Sleep?
Is there a sleep duration sweet spot to decrease your risk of heart attacks? According to researchers from the University of Colorado: Boulder, there is! T...
SEP 18, 2019
SEP 18, 2019
Clear, Flexible Vital Sign Wearable Monitors
Wearable health monitors are gaining in popularity, both for fitness tracking and for gathering more targeted health data relating to heart disease and oth...
OCT 25, 2019
OCT 25, 2019
Cardiac Mapping for Arrhythmia Diagnosis
Cardiac mapping is an essential diagnostic tool. These imagining tools are used for diagnosing arrhythmias in the heart. Cardiac mapping can be done in sev...
JAN 09, 2020
JAN 09, 2020
Increased Autism Risk for Children Born with Heart Disease
Children born with congenital heart disease (CHD) have a life expectancy comparable to that of the general population. However, despite advances in medical...
Loading Comments...